Holding(s) in Company

Cambridge Antibody Tech Group PLC
23 December 2004

                                  SCHEDULE 10

                   NOTIFICATION OF MAJOR INTERESTS IN SHARES


1)   Name of company

Cambridge Antibody Technology Group plc

2)   Name of shareholder having a major interest

Finsbury Worldwide Pharmaceutical Trust plc

3)   Please state whether notification indicates that it is in respect of
     holding of the shareholder named in 2 above or in respect of a
     non-beneficial interest or in the case of an individual holder if it is a
     holding of that person's spouse or children under the age of 18


As in 2 above


4)   Name of the registered holder(s) and, if more than one holder, the
     number of shares held by each of them


Bank of New York (Nominees) Limited as nominee for Finsbury Worldwide
Pharmaceutical Trust plc


5)   Number of shares/amount of stock acquired

Nil


6)   Percentage of issued class

Nil

7)   Number of shares/amount of stock disposed

500,000

8)   Percentage of issued class

0.971%

9)   Class of security

Ordinary 10 pence shares

10)  Date of transaction

20 December 2004

11)  Date company informed

22 December 2004

12)  Total holding following this notification

600,000 Ordinary 10 pence shares



13)  Total percentage holding of issued class following this notification

1.166%

14)  Any additional information

Finsbury Wordlwide Pharmaceutical Trust plc no longer have a notifiable interest


15)  Name of contact and telephone number for queries

Justin Hoskins 01223 898589

16)  Name and signature of authorised company official responsible for
     making this notification


Diane Mellett, Company Secretary



Date of notification: 23 December 2004





                      This information is provided by RNS
            The company news service from the London Stock Exchange